The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 03, 2013

Filed:

May. 25, 2012
Applicants:

Arthur B. Raitano, Los Angeles, CA (US);

Aya Jakobovits, Beverly Hills, CA (US);

Pia M. Challita-eid, Encino, CA (US);

Steven B. Kanner, Santa Monica, CA (US);

Wangmao GE, Tampa, FL (US);

Juan J. Perez-villar, Santa Monica, CA (US);

Robert Kendall Morrison, Santa Monica, CA (US);

Inventors:

Arthur B. Raitano, Los Angeles, CA (US);

Aya Jakobovits, Beverly Hills, CA (US);

Pia M. Challita-Eid, Encino, CA (US);

Steven B. Kanner, Santa Monica, CA (US);

Wangmao Ge, Tampa, FL (US);

Juan J. Perez-Villar, Santa Monica, CA (US);

Robert Kendall Morrison, Santa Monica, CA (US);

Assignee:

Agensys, Inc., Santa Monica, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

A novel gene 158P3D2 and its encoded protein, and variants thereof, are described wherein 158P3D2 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 158P3D2 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 158P3D2 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 158P3D2 can be used in active or passive immunization.


Find Patent Forward Citations

Loading…